Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A43460 | 31663469 | Curr Med Chem | Effects of Pterostilbene on Diabetes, Liver Steatosis and Serum Lipids. | 2021 | Details |
| A43470 | 31633718 | Arq Gastroenterol | NONALCOHOLIC FATTY LIVER DISEASE (NAFLD), MORE THAN A LIVER DISEASE. | 2019 | Details |
| A43475 | 31613385 | Hepatology | Reply. | 2020 | Details |
| A43476 | 31611648 | Nat Rev Endocrinol | The clinical potential of circulating microRNAs in obesity. | 2019 | Details |
| A43478 | 31610029 | Hepatology | Letter to the Editor: Intrahepatic Lipid Content After Insulin Glargine Addition to Metformin in Type II Diabetes Mellitus With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A43496 | 31584530 | J Cardiovasc Pharmacol | NLRP3 Inflammasome: A Novel Player in Metabolically Induced Inflammation-Potential Influence on the Myocardium. | 2019 | Details |
| A43497 | 31582899 | Mediators Inflamm | Pattern Recognition Receptor-Mediated Chronic Inflammation in the Development and Progression of Obesity-Related Metabolic Diseases. | 2019 | Details |
| A43506 | 31566590 | Pol Arch Intern Med | Pentraxin 3 in patients with type 2 diabetes and nonalcoholic fatty liver disease: a promising treatment target for glucagon-like peptide-1 receptor agonists. | 2019 | Details |
| A43507 | 31566589 | Pol Arch Intern Med | Pentraxin 3 in patients with type 2 diabetes and nonalcoholic fatty liver disease: a promising treatment target for glucagon-like peptide-1 receptor agonists. Authors' reply. | 2019 | Details |
| A43508 | 31559328 | GE Port J Gastroenterol | Mauriac Syndrome: A Rare Hepatic Glycogenosis in Poorly Controlled Type 1 Diabetes. | 2019 | Details |
| A43514 | 31538647 | Clin Infect Dis | Nonalcoholic Fatty Liver Disease in Human Immunodeficiency Virus: The (Not So) New Kid on the Block? | 2020 | Details |
| A43515 | 31538645 | Clin Infect Dis | Reply to Krahn and Sebastiani. | 2020 | Details |
| A43518 | 31532551 | Aliment Pharmacol Ther | Letter: metformin treatment and hepatocellular carcinoma risk in non-alcoholic fatty liver disease. Authors' reply. | 2019 | Details |
| A43519 | 31532548 | Aliment Pharmacol Ther | Letter: metformin treatment and hepatocellular carcinoma risk in non-alcoholic fatty liver disease. | 2019 | Details |
| A43521 | 31531370 | Biomed Res Int | Metabolic Comorbidities and Risk of Development and Severity of Drug-Induced Liver Injury. | 2019 | Details |
| A43541 | 31464785 | Eur J Gastroenterol Hepatol | Transient elastography for assessing severe hepatic fibrosis in diabetic patients with nonalcoholic fatty liver disease: definitions matter. | 2019 | Details |
| A43558 | 31414538 | Aliment Pharmacol Ther | Editorial: it is not a wide-open field for incretins - collateral benefits favour the use of metformin in advanced non-alcoholic steatohepatitis. | 2019 | Details |
| A43578 | 31359473 | Aliment Pharmacol Ther | Letter: improvement of clinical outcomes by metformin in metabolic liver disease-a microbiota-dependent mechanism? | 2019 | Details |
| A43604 | 31301829 | J Dairy Sci | Invited review: Sphingolipid biology in the dairy cow: The emerging role of ceramide. | 2019 | Details |
| A43611 | 31294797 | J Burn Care Res | The Influence of Obesity on Treatment and Outcome of Severely Burned Patients. | 2019 | Details |
| A43613 | 31290314 | J Proteome Res | Lipidomics Reveals Similar Changes in Serum Phospholipid Signatures of Overweight and Obese Pediatric Subjects. | 2019 | Details |
| A43615 | 31284360 | Gut Liver | Nonalcoholic Fatty Liver Disease Is a Stepping Stone in the Path toward Diabetes Mellitus. | 2019 | Details |
| A43639 | 31237448 | Am J Physiol Endocrinol Metab | Obeticholic acid ameliorates dyslipidemia but not glucose tolerance in mouse model of gestational diabetes. | 2019 | Details |
| A43641 | 31229271 | J Hepatol | Liver transplantation for non-alcoholic steatohepatitis in Europe: Where do we stand? | 2019 | Details |
| A43646 | 31225638 | Br J Dermatol | Management of psoriasis as a systemic disease: what is the evidence? | 2019 | Details |
| A43650 | 31200402 | Klin Lab Diagn | [Insulin resistance is an alimentary deficiency of energy substrates (glucose) in the biological reaction of exotrophy and aphysiology compensation by fatty acids via the biological reaction of endothrophy.] | 2019 | Details |
| A43653 | 31185002 | Am J Gastroenterol | Pancreatic Steatosis: An Emerging Clinical Entity. | 2019 | Details |
| A43658 | 31167890 | Diabetes Care | Fatty Liver Among Adolescent Offspring of Women With Type 1 Diabetes (the EPICOM Study). | 2019 | Details |
| A43668 | 31149289 | Acta Endocrinol (Buchar) | NON-INVASIVE ASSESSMENT OF LIVER STEATOSIS AND FIBROSIS USING TRANSIENT ELASTOGRAPHY AND CONTROLLED ATTENUATION PARAMETER IN TYPE 2 DIABETES PATIENTS. | 2022 | Details |
| A43693 | 31096219 | Ann Nutr Metab | Youth-Onset Type 2 Diabetes Manifestations in other Specialties: Its Many Disguises. | 2019 | Details |
| A43708 | 31062325 | Adv Exp Med Biol | The Full Spectrum of Alzheimer's Disease Is Rooted in Metabolic Derangements That Drive Type 3 Diabetes. | 2019 | Details |
| A43712 | 31060980 | Acad Radiol | Imaging Biomarkers for Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A43717 | 31040498 | Mo Med | Pediatric Fatty Liver Disease. | 2019 | Details |
| A43731 | 31006135 | Hepatology | Incretin-Based Therapies for the Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes. | 2019 | Details |
| A43745 | 30985734 | Transplantation | The Impact of Preexisting and Post-transplant Diabetes Mellitus on Outcomes Following Liver Transplantation. | 2019 | Details |
| A43748 | 30971482 | Neurology | Toxic diffuse isolated cerebellar edema from over-the-counter health supplements. | 2019 | Details |
| A43751 | 30963964 | Curr Med Chem | Role of Dietary Gluten in Development of Celiac Disease and Type I Diabetes: Management Beyond Gluten-Free Diet. | 2020 | Details |
| A43762 | 30945509 | Zhen Ci Yan Jiu | [Progress of researches on mechanisms of acupuncture therapy for insulin resistance]. | 2019 | Details |
| A43779 | 30901133 | Diabetes Metab Res Rev | Prevalence of diabetes in liver cirrhosis: A systematic review and meta-analysis. | 2019 | Details |
| A43800 | 30847693 | Dig Dis Sci | Fat and Fibrosis: Does Empagliflozin Impair the Progression of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus? | 2020 | Details |
| A43811 | 30821517 | Curr Med Res Opin | Response: non-alcoholic steatohepatitis and type 2 diabetes mellitus: the effects of weight loss versus drug treatment. | 2019 | Details |
| A43813 | 30819009 | Curr Med Res Opin | Non-alcoholic steatohepatitis and type 2 diabetes mellitus: the effects of weight loss versus drug treatment. | 2019 | Details |
| A43815 | 30816074 | Curr Vasc Pharmacol | Menopause and its Cardiometabolic Consequences: Current Perspectives. | 2019 | Details |
| A43826 | 30771497 | Clin Gastroenterol Hepatol | Fibroscan for the Rest of Us-How to Incorporate Fibroscan Into Management of Patients With Liver Disease. | 2019 | Details |
| A43827 | 30770439 | Proc Natl Acad Sci U S A | PGC1A regulates the IRS1:IRS2 ratio during fasting to influence hepatic metabolism downstream of insulin. | 2019 | Details |
| A43841 | 30734078 | Chirurg | [Metabolic surgery]. | 2019 | Details |
| A43845 | 30706731 | Diab Vasc Dis Res | Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetes. | 2019 | Details |
| A43846 | 30705513 | J Clin Biochem Nutr | 5-Aminolevulinic acid with ferrous iron improves early renal damage and hepatic steatosis in high fat diet-induced obese mice. | 2018 | Details |
| A43860 | 30670052 | Lipids Health Dis | Effects of exercise training on Fetuin-a in obese, type 2 diabetes and cardiovascular disease in adults and elderly: a systematic review and Meta-analysis. | 2019 | Details |
| A43869 | 30648577 | J Food Drug Anal | Identification of baicalin from Bofutsushosan and Daisaikoto as a potent inducer of glucose uptake and modulator of insulin signaling-associated pathways. | 2018 | Details |
| A43871 | 30641759 | Diabetes Metab Syndr | Relationship between glucagon like peptide-1 and non-alcoholic fatty liver disease in diabetic and non-diabetic patients. | 2018 | Details |
| A43876 | 30615269 | Liver Int | Reply to Mantovani: "Causality between non-alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes". | 2019 | Details |
| A43893 | 30548562 | Liver Int | Causality between non-alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes. | 2019 | Details |
| A43899 | 30503805 | Metabolism | Research developments in metabolism 2018. | 2018 | Details |
| A43913 | 30473472 | Hepatobiliary Pancreat Dis Int | Statins, diabetes, obesity, nonalcoholic fatty liver disease, and hepatocellular carcinoma. | 2018 | Details |
| A43939 | 30403316 | J Intern Med | Precision medicine in type 2 diabetes. | 2018 | Details |
| A43953 | 30362994 | Eur J Gastroenterol Hepatol | Overlooked muscle cramps in patients with chronic liver disease: in relation to the prevalence of muscle cramps. | 2019 | Details |
| A43955 | 30348897 | Mol Pharmacol | The 5'-AMP-Activated Protein Kinase Regulates the Function and Expression of Human Organic Anion Transporting Polypeptide 1A2. | 2018 | Details |
| A43957 | 30325692 | Metab Syndr Relat Disord | Determinants of Fasting Hyperglucagonemia in Patients with Type 2 Diabetes and Nondiabetic Control Subjects. | 2018 | Details |
| A43961 | 30316414 | Fertil Steril | Beyond fertility: polycystic ovary syndrome and long-term health. | 2018 | Details |
| A43989 | 30215326 | Cardiovasc Hematol Agents Med Chem | Cardiovascular and Hematological Medicine in 2018 - Advances and Insights. | 2019 | Details |
| A43992 | 30203590 | Helicobacter | Helicobacter pylori and extragastric diseases. | 2018 | Details |
| A44019 | 30143184 | Lancet Diabetes Endocrinol | Non-alcoholic fatty liver disease concerns with glucokinase activators. | 2018 | Details |
| A44025 | 30119271 | Biomed Pharmacother | Diabetes and hepatocellular carcinoma: A pathophysiological link and pharmacological management. | 2018 | Details |
| A44075 | 29943682 | Br J Biomed Sci | Impact of non-alcoholic fatty liver disease on pregnancy. | 2018 | Details |
| A44078 | 29936174 | Metabolism | Potential impact of Helicobacter pylori-related metabolic syndrome on upper and lower gastrointestinal tract oncogenesis. | 2018 | Details |
| A44110 | 29731078 | Transplant Proc | Diabetes With or Without Hypertension Does Not Affect Graft Survival and All-cause Mortality After Liver Transplant: A Propensity Score Matching Analysis. | 2018 | Details |
| A44113 | 29709217 | Hepatobiliary Pancreat Dis Int | Glycogenic hepatopathy. | 2018 | Details |
| A44116 | 29702499 | Curr Opin Cardiol | New antihyperglycaemic agents and cardiovascular disease: let's be optimistic. | 2018 | Details |
| A44127 | 29651702 | Hepatol Int | Tsumura-Suzuki obese diabetic mice-derived hepatic tumors closely resemble human hepatocellular carcinomas in metabolism-related genes expression and bile acid accumulation. | 2018 | Details |
| A44144 | 29601089 | Hepatology | Reply. | 2018 | Details |
| A44147 | 29589988 | J Laparoendosc Adv Surg Tech A | Laparoscopic Sleeve Gastrectomy for Morbid Obesity at a Veterans Affairs Medical Center. | 2018 | Details |
| A44150 | 29574875 | Aliment Pharmacol Ther | Editorial: diabetes, obesity and clinical inertia-the recipe for advanced NASH. Authors' reply. | 2018 | Details |
| A44208 | 29404432 | Hepatol Commun | Effects of a sodium-glucose cotransporter 2 inhibitor in nonalcoholic fatty liver disease complicated by diabetes mellitus: Preliminary prospective study based on serial liver biopsies. | 2017 | Details |
| A44212 | 29373534 | Nutrients | Betaine Supplementation Enhances Lipid Metabolism and Improves Insulin Resistance in Mice Fed a High-Fat Diet. | 2018 | Details |
| A44249 | 29250524 | Front Nutr | Editorial: Are Rodent Models Fit for Investigation of Human Obesity and Related Diseases? | 2017 | Details |
| A44285 | 29160303 | Pharmacogenomics J | The PNPLA3 I148M variant is associated with transaminase elevations in type 2 diabetes patients treated with basal insulin peglispro. | 2017 | Details |
| A44304 | 29091323 | J Viral Hepat | Lower levels of dehydroepiandrosterone sulfate are associated with more advanced liver fibrosis in chronic hepatitis C. | 2017 | Details |
| A44323 | 29019968 | Nature | Fighting the fatty liver. | 2017 | Details |
| A44329 | 28984071 | Diabetes Metab Res Rev | Type 2 diabetes: Does pancreatic fat really matter? | 2017 | Details |
| A44342 | 28912810 | Int J Endocrinol | Latent Inflammation and Insulin Resistance in Adipose Tissue. | 2017 | Details |
| A44345 | 28901968 | Curr Opin Obstet Gynecol | Medical comorbidity in polycystic ovary syndrome with special focus on cardiometabolic, autoimmune, hepatic and cancer diseases: an updated review. | 2017 | Details |
| A44352 | 28867686 | Endocr J | Impact of fatty liver disease and metabolic syndrome on incident type 2 diabetes; a population based cohort study. | 2017 | Details |
| A44372 | 28795381 | Chin J Integr Med | Research progress on prevention and treatment of glucolipid metabolic disease with integrated traditional Chinese and Western medicine. | 2017 | Details |
| A44385 | 28744408 | Am J Cancer Res | The role of thiazolidinediones in hepatocellular carcinoma risk reduction: a population-based cohort study in Taiwan. | 2017 | Details |
| A44425 | 28668407 | Eur J Radiol | Current and cutting-edge interventions for the treatment of obese patients. | 2017 | Details |
| A44426 | 30191057 | Hepat Oncol | Nonalcoholic fatty liver disease and hepatocellular carcinoma. | 2017 | Details |
| A44469 | 28521334 | Nutr Rev | Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation. | 2017 | Details |
| A44470 | 28514463 | JAMA Dermatol | Pediatric Psoriasis Comorbidity Screening Guidelines. | 2017 | Details |
| A44473 | 28513098 | J Diabetes | Non-alcoholic fatty liver disease and type 2 diabetes: Importance of glycemic control. | 2017 | Details |
| A44496 | 28468762 | Gut | Pioglitazone for the treatment of NASH in patients with prediabetes or type 2 diabetes mellitus-authors' response. | 2017 | Details |
| A44499 | 28463859 | Curr Opin Lipidol | Adiponectin, lipids and atherosclerosis. | 2017 | Details |
| A44500 | 28459766 | Curr Opin Lipidol | Mode of action of berberine on lipid metabolism: a new-old phytochemical with clinical applications? | 2017 | Details |
| A44501 | 28459036 | Indian J Endocrinol Metab | Consensus Statement on Dose Modifications of Antidiabetic Agents in Patients with Hepatic Impairment. | 2020 | Details |
| A44512 | 28408383 | Gut | Pioglitazone for the treatment of NASH in patients with prediabetes or type 2 diabetes mellitus. | 2017 | Details |
| A44543 | 28292408 | Gastrointest Endosc Clin N Am | Hydrothermal Duodenal Mucosal Resurfacing: Role in the Treatment of Metabolic Disease. | 2017 | Details |
| A44544 | 28292400 | Gastrointest Endosc Clin N Am | Surgical Treatment of Obesity and Diabetes. | 2017 | Details |
| A44546 | 28285710 | Cell Immunol | Role of immune cells in obesity induced low grade inflammation and insulin resistance. | 2017 | Details |
| A44551 | 28242319 | Clin Gastroenterol Hepatol | White Paper AGA: POWER - Practice Guide on Obesity and Weight Management, Education, and Resources. | 2017 | Details |
| A44558 | 28212760 | J Am Acad Dermatol | Psoriasis and comorbid diseases: Implications for management. | 2017 | Details |